The reduction in circulating SCFAs, showcased in our results, may contribute significantly to the decrease in insulin sensitivity and the development of insulin resistance, a major clinical feature of PCOS (Stener-Victorin et al., 2024; Canfora et al., 2015). This evidence concerns the gene INS and polycystic ovary syndrome.